The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms

NCT05562232 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-07-12

No results posted yet for this study

Summary

The purpose of this study, is to investigate whether creatine monohydrate as a supplement reduces the number and severity of symptoms in patients with persistent post-concussive symptoms through self-reported post-concussion symptoms questionnaires.

Conditions

  • Mild Traumatic Brain Injury
  • Concussion, Brain

Interventions

DIETARY_SUPPLEMENT

Creatine Monohydrate

Follows

Sponsors & Collaborators

  • University of Southern Denmark

    collaborator OTHER
  • Psychiatric Research Unit, Region Zealand, Denmark

    lead OTHER

Principal Investigators

  • Michael Marcussen, Dr. · University of Southern Denmark (SDU), Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-08-31
Completion
2024-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05562232 on ClinicalTrials.gov